Smarter. Stronger. Together: Optimizing Personalized Triple-Negative Breast Cancer Care for Providers and Patients

Download these slides from a live webinar to gain more insight into optimal approaches for the management of patients with TNBC.

Mark Pegram, MD Sara Tolaney, MD, MPH Released: December 5, 2022

In this on-demand webcast from a live webinar, Mark Pegram, MD, and Sara Tolaney, MD, MPH, review the current data on the optimal management strategies for patients with TNBC.

Mark Pegram, MD Sara Tolaney, MD, MPH Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Physician Assistants: 1.0 AAPA Category 1 CME credit Released: January 12, 2023 Expired: No longer available for credit

Read this expert commentary discussing a 44-year-old woman with recurring advanced TNBC who received treatment with sacituzumab govitecan, an FDA-approved Trop-2–directed antibody and topoisomerase inhibitor conjugate, in the relapsed/refractory setting.

Laura M. Spring, MD Released: November 14, 2022

In this commentary, expert faculty address frequently asked questions about the current optimal treatment of patients with triple-negative breast cancer.

Mark Pegram, MD Sara Tolaney, MD, MPH Released: January 31, 2023

In this podcast episode, listen to breast cancer experts Mark Pegram, MD, and Sara Tolaney, MD, MPH, engage in a discussion from a live CCO Cancer Conversations webinar on optimal treatment strategies for patients with TNBC.

Mark Pegram, MD Sara Tolaney, MD, MPH Released: January 18, 2023

Download this short slideset of key points from a podcast on current optimal approaches for the management of patients with TNBC.

Mark Pegram, MD Sara Tolaney, MD, MPH Released: January 18, 2023